Effectiveness of Transcranial Direct Current in Patients With Persistent COVID-19 With Headaches and Chronic Pain.

Last updated: June 12, 2023
Sponsor: Fundación Universidad Católica de Valencia San Vicente Mártir
Overall Status: Active - Recruiting

Phase

N/A

Condition

Muscle Pain

Oral Facial Pain

Acute Pain

Treatment

Transcranial Direct Current Therapy (tDCS)

Clinical Study ID

NCT05780450
UCV/2021-2022/140
  • Ages > 16
  • All Genders

Study Summary

This study aims to verify the efficacy / effectiveness of treatment with transcranial direct therapy (TDCS) in patients with Persistent Covid who present headaches, migraines and chronic pain, such as arthralgias and myalgias.

Transcranial Direct Therapy is used in the field of Physiotherapy and Rehabilitation, with results that prove to be effective for the treatment of patients suffering from symptoms such as migraines, headaches, chronic pain, fibromyalgia or chronic neuropathic pain.

As can be seen, in the case of patients with Persistent Covid we find several of these symptoms, so it is suggested that, if Transcranial Direct Current Therapy (TDCs) is giving such good results, relieving these symptoms, why can not give such good results and help so much in patients with Persistent Covid, If many of the symptoms are the same, even if the origin or cause is different.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients with Persistent Covid
  • Men and women
  • All ages from 16 years old
  • Patients who passed the Covid in its acute phase in an asymptomatic, mild and severeway.

Exclusion

Exclusion Criteria:

  • Patients without confirmation with positive PCR in the acute phase of Covid-19
  • Patients with Persistent Covid who do not have at least one of these symptoms:migraines, headaches, chronic pain, neuropathic pain, arthralgia, myalgias
  • Patients with pacemaker / defibrillator
  • Patients with brain implants
  • Patients with cranial fractures
  • Pregnant

Study Design

Total Participants: 27
Treatment Group(s): 1
Primary Treatment: Transcranial Direct Current Therapy (tDCS)
Phase:
Study Start date:
April 01, 2023
Estimated Completion Date:
July 31, 2023

Connect with a study center

  • Clínica Paiporta

    Paiporta, Valencia 46200
    Spain

    Active - Recruiting

  • Escuela de Doctorado. Universidad Católica de Valencia San Vicente Mártir. (Doctoral School. Catholic University of Valencia San Vicente Mártir)

    Valencia, 46001
    Spain

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.